Cardiac transplantation provides definitive management of severe heart failure in selected
patients who have exhausted all other options. The results of transplantation have improved …

Objectives: This study sought to evaluate the use of a continuous-flow rotary left ventricular
assist device (LVAD) as a bridge to heart transplantation. Background: LVAD therapy is an …

Left ventricular assist devices (LVADs) have emerged as a beneficial therapeutic strategy
proven to improve the morbidity and mortality of patients with advanced heart failure …

Recent outstanding clinical advances with new mechanical circulatory systems have led to
additional strategies in the treatment of end-stage heart failure. Heart transplantation can be …

Heart transplantation remains a limited option in the treatment of patients with end-stage
heart failure because of the shortage of donors and the high incidence of heart failure …

Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have
led to additional strategies in the treatment of end stage heart failure (HF). Heart …

Heart failure remains a significant cause of morbidity and mortality, affecting over five million
patients in the United States. Continuous-flow left ventricular assist devices (LVAD) have …

Background: Heart transplantation remains the definitive therapy for patients with advanced
heart failure; however, owing to limited donor organ availability and long wait times …

Continuous-flow (CF) left ventricular assist devices (LVADs) have become the standard of
care for patients with advanced heart failure refractory to optimal medical therapy. The goal …

Objective This study assessed the early and late outcomes after cardiac transplantation in
patients receiving long-term continuous-flow left ventricular assist device (CF-LVAD) …